Clinical trial
Effect of Lipoprotein(a) Elimination by Lipoprotein Apheresis on Cardiovascular…
NCT02791802 · Technische Universität Dresden, Other · Unknown status
Key facts
| NCT number | NCT02791802 |
|---|---|
| Title | Effect of Lipoprotein(a) Elimination by Lipoprotein Apheresis on Cardiovascular Outcomes |
| Official title | A European Multicenter Study on the Effect of Lipoprotein(a) Elimination by Lipoprotein Apheresis on Cardiovascular Outcomes |
| Acronym | MultiSELECt |
| Lead sponsor | Technische Universität Dresden, Other |
| Collaborators | Kaneka Pharma Europe N.V. Industry |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Lipoprotein Types--Lp System Lp(A) Hyperlipoproteinemia |
| Enrollment | 1,000 |
| Start date | Aug 1, 2016 |
| Primary completion | Dec 1, 2022 |
| Completion | Dec 1, 2022 |
| First posted | Jun 7, 2016 |
| Last update posted | May 2, 2022 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: